photo of exercise equipment, bowl of oatmeal and apples, a measuring tape, workout shoes, and a weight scale

National Heart, Lung, and Blood Institute (NHLBI) Obesity, Nutrition, and Physical Activity (ONPA) Seminar Series: A New Era in Pediatric Obesity Treatment: GLP-1RAs, Precision Medicine, and Defining Success Beyond Weight Loss Alone

Event Details

December 16, 2026 12:00 PM
to
December 16, 2026 1:00 PM
Virtual

Share

Description

In this 1-hour virtual seminar, Jaime Moore, M.D., M.P.H., will discuss the rapidly evolving landscape of pediatric obesity treatment, including the emergence of glucagon-like peptide-1 receptor agonists (GLP-1RAs), which presents an unprecedented opportunity to improve cardiometabolic health, as well as a responsibility to carefully evaluate the balance of risks and benefits. This presentation will highlight a research portfolio that includes studies of obesity pharmacotherapy (phentermine, topiramate, and GLP-1 receptor agonists) and bariatric surgery in youth, conducted through both traditional randomized controlled trials and real-world clinical settings. It will also highlight clinical research approaches to studying the heterogeneity of treatment effects through physiologic phenotyping, as well as unique considerations for obesity treatment in adolescents (versus adults) and in youth with intellectual and developmental disabilities.

Looking ahead, the presentation will explore a vision for more precise and personalized obesity care for children and adolescents. Can we better predict which children will develop specific obesity-related complications, and when, and which treatments will provide the greatest sustained cardiometabolic benefit with the fewest adverse effects? Additional emerging research priorities include understanding how GLP-1RAs and other obesity treatments affect body composition and related functional outcomes, nutrition, eating behaviors, and mental health, as well as quantifying the long-term clinical and economic benefits of early, effective intervention through the prevention or delay of major cardiometabolic complications. Ultimately, translating these advances from research into clinical practice and evidence-based policy will be essential for improving access and maximizing the lifelong health impact of obesity treatment.

About the Speaker:

Jaime Moore, M.D., M.P.H.
University of Colorado Anschutz | Children's Hospital Colorado

photo of Jamie MooreJaime M. Moore, M.D., M.P.H., is an Associate Professor in the Department of Pediatrics, Section of Nutrition, at the University of Colorado Anschutz. She is board-certified in Internal Medicine, Pediatrics, and Obesity Medicine, with an M.P.H. in Community and Behavioral Health. Dr. Moore is the clinical medical director of the Lifestyle Medicine primary pediatric obesity program at Children’s Hospital Colorado, which serves the Rocky Mountain West. She cares for patients in Lifestyle Medicine and the Bariatric Surgery Center at Children’s Hospital Colorado and serves as an attending on the inpatient Nutrition physician consultation service.

She also serves as the clinical research director for Pediatric Nutrition at the University of Colorado Anschutz. Her own research focuses on personalizing obesity treatment using a combination of tools (lifestyle, pharmacotherapy, and bariatric surgery), better understanding the heterogeneity in response to these treatments, and helping to define success beyond weight loss alone. FDA approval of contemporary, biologically focused obesity medications, including glucagon-like peptide-1 receptor agonists, has prompted many new and exciting research questions to pursue, with the overarching goal of improving precision care for youth with obesity.

If you have questions for Dr. Moore, please email them to ONPA@mail.nih.gov.

No registration is required, and there is no fee to attend. The seminar can be viewed after December 16th on the NIH VideoCast website under Past Events: https://videocast.nih.gov/past-events.

Individuals requiring Sign Language Interpreters or other reasonable accommodations to facilitate their participation in this event should contact Susan Holbrook at susan.holbrook@nih.gov at least five (5) days prior to the commencement of the event.

Zoom Webinar

View the webinar: https://nih.zoomgov.com/j/1657237354.